Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Oncology News

ESMO oncology news aims to keep you up to date with the developments that affect you and your daily practice. 

Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.

Filter by:

1548 results

Cytotoxic Therapy;  Breast Cancer;  Ovarian Cancer;  Haematological Malignancies;  Neuroendocrine Neoplasms

EMA Recommends Granting a Marketing Authorisation for Melphalan

A new hybrid medicine is intended for the treatment of certain haematological and other cancers and as reduced intensity conditioning treatment prior to allo-HSCT in haematological diseases.

Targeted Therapy;  Ovarian Cancer

EMA Recommends Extension of Indications for Niraparib

New indication concerns maintenance treatment of adults with advanced ovarian cancer who are in response following completion of first-line platinum-based chemotherapy

Immunotherapy;  Hepatobiliary Cancers

EMA Recommends Extension of Indications for Atezolizumab

New indication concerns a combination with bevacizumab for the treatment of adults with advanced or unresectable hepatocellular carcinoma who have not received prior systemic therapy

Targeted Therapy;  Prostate Cancer;  Ovarian Cancer

EMA Recommends Extension of Indications for Olaparib

New indications concern the maintenance treatment in combination with bevacizumab of ovarian cancer with HRD positive status and monotherapy of mCRPC with BRCA1/2 mutations 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.